This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of retroperitoneum and peritoneum (controls excluding all cancers)
C3_RETROPERITONEUM_PERITONEUM_EXALLC
No definition available.
Endpoint definition
↥individuals
Apply sex-specific rule None
Check conditions None
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Include endpoints None
-
Remove individuals based on genotype QC
164
Control definitions
Extra metadata
No upset plot: script not run.
No upset table: script not run.
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of retroperitoneum and peritoneum (controls excluding all cancers)
based on the number of shared cases.
Broader endpoints:
- Malignant neoplasm of retroperitoneum and peritoneum
- Malignant neoplasm of mesothelium and soft tissue
- Malignant neoplasm of mesothelium and soft tissue (controls excluding all cancers)
- Malignant neoplasm (controls excluding all cancers)
- Malignant neoplasm
Narrower endpoints:
Summary Statistics
↥Key figures
All | Female | Male | |
---|---|---|---|
Number of individuals | 164 | 110 | 54 |
Unadjusted prevalence (%) | 0.04 | 0.05 | 0.03 |
Mean age at first event (years) | 63.58 | 63.63 | 63.48 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: C3_RETROPERITONEUM_PERITONEUM_EXALLC – Malignant neoplasm of retroperitoneum and peritoneum (controls excluding all cancers)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Malignant neoplasm of retroperitoneum and peritoneum (controls excluding all cancers)
↥Endpoint not on priority list, no data to show.